Literature DB >> 15373840

Subproteomics analysis of Ca+-binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle.

Philip Doran1, Paul Dowling, James Lohan, Karen McDonnell, Stephan Poetsch, Kay Ohlendieck.   

Abstract

Duchenne muscular dystrophy represents one of the most common hereditary diseases. Abnormal ion handling is believed to render dystrophin-deficient muscle fibres more susceptible to necrosis. Although a reduced Ca(2+) buffering capacity has been shown to exist in the dystrophic sarcoplasmic reticulum, surprisingly no changes in the abundance of the main luminal Ca(2+) reservoir protein calsequestrin have been observed in microsomal preparations. To address this unexpected finding and eliminate potential technical artefacts of subcellular fractionation protocols, we employed a comparative subproteomics approach with total mouse skeletal muscle extracts. Immunoblotting, mass spectrometry and labelling of the entire muscle protein complement with the cationic carbocyanine dye 'Stains-All' was performed in order to evaluate the fate of major Ca(2+)-binding proteins in dystrophin-deficient skeletal muscle fibres. In contrast to a relatively comparable expression pattern of the main protein population in normal vs. dystrophic fibres, our analysis showed that the expression of key Ca(2+)-binding proteins of the luminal sarcoplasmic reticulum is drastically reduced. This included the main terminal cisternae constituent, calsequestrin, and the previously implicated Ca(2+)-shuttle element, sarcalumenin. In contrast, the 'Stains-All'-positive protein spot, representing the cytosolic Ca(2+)-binding component, calmodulin, was not changed in dystrophin-deficient fibres. The reduced 2D 'Stains-All' pattern of luminal Ca(2+)-binding proteins in mdx preparations supports the calcium hypothesis of muscular dystrophy. The previously described impaired Ca(2+) buffering capacity of the dystrophic sarcoplasmic reticulum is probably caused by a reduction in luminal Ca(2+)-binding proteins, including calsequestrin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15373840     DOI: 10.1111/j.1432-1033.2004.04332.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  35 in total

1.  Comparative proteomic profiling of dystroglycan-associated proteins in wild type, mdx, and Galgt2 transgenic mouse skeletal muscle.

Authors:  Jung Hae Yoon; Eric Johnson; Rui Xu; Laura T Martin; Paul T Martin; Federica Montanaro
Journal:  J Proteome Res       Date:  2012-07-30       Impact factor: 4.466

Review 2.  Proteomic profiling of x-linked muscular dystrophy.

Authors:  Caroline Lewis; Steven Carberry; Kay Ohlendieck
Journal:  J Muscle Res Cell Motil       Date:  2009-12       Impact factor: 2.698

3.  Comparison of the myoplasmic calcium transient elicited by an action potential in intact fibres of mdx and normal mice.

Authors:  Stephen Hollingworth; Ulrike Zeiger; Stephen M Baylor
Journal:  J Physiol       Date:  2008-09-04       Impact factor: 5.182

4.  Proteomic profiling of the mouse diaphragm and refined mass spectrometric analysis of the dystrophic phenotype.

Authors:  Sandra Murphy; Margit Zweyer; Maren Raucamp; Michael Henry; Paula Meleady; Dieter Swandulla; Kay Ohlendieck
Journal:  J Muscle Res Cell Motil       Date:  2019-03-19       Impact factor: 2.698

5.  Changes in calsequestrin, TNF-α, TGF-β and MyoD levels during the progression of skeletal muscle dystrophy in mdx mice: a comparative analysis of the quadriceps, diaphragm and intrinsic laryngeal muscles.

Authors:  Juliana Barros Maranhão; Drielen de Oliveira Moreira; Adriana Fogagnolo Maurício; Samara Camaçari de Carvalho; Renato Ferretti; Juliano Alves Pereira; Humberto Santo Neto; Maria Julia Marques
Journal:  Int J Exp Pathol       Date:  2015-10-30       Impact factor: 1.925

Review 6.  Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances.

Authors:  Guy L Odom; Paul Gregorevic; Jeffrey S Chamberlain
Journal:  Biochim Biophys Acta       Date:  2006-09-26

7.  Analysis of ischemic muscle in patients with peripheral artery disease using X-ray spectroscopy.

Authors:  Ryan A Becker; Kim Cluff; Nithyanandhi Duraisamy; George P Casale; Iraklis I Pipinos
Journal:  J Surg Res       Date:  2017-07-25       Impact factor: 2.192

8.  Overexpression of SERCA1a in the mdx diaphragm reduces susceptibility to contraction-induced damage.

Authors:  Kevin J Morine; Meg M Sleeper; Elisabeth R Barton; H Lee Sweeney
Journal:  Hum Gene Ther       Date:  2010-12       Impact factor: 5.695

9.  Calcium-binding proteins in skeletal muscles of the mdx mice: potential role in the pathogenesis of Duchenne muscular dystrophy.

Authors:  Adriana Pertille; Candida Luiza Tonizza de Carvalho; Cintia Yuri Matsumura; Humberto Santo Neto; Maria Julia Marques
Journal:  Int J Exp Pathol       Date:  2009-12-03       Impact factor: 1.925

10.  Proteomic Profiling of the Dystrophin-Deficient MDX Heart Reveals Drastically Altered Levels of Key Metabolic and Contractile Proteins.

Authors:  Caroline Lewis; Harald Jockusch; Kay Ohlendieck
Journal:  J Biomed Biotechnol       Date:  2010-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.